$セラス ライフサイエンシズ グループ(SLS.US)$ NEWS SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level SELLAS Life Sciences Group, Inc. announces positive Phase 2 preliminary data of SLS009 in relapsed/refractory acute myeloid leukemia (r/r AML), achieving a 100% response rate in patients with ASXL1 mutation at the optimal dose level. The company has filed IP protection related to the ASXL1 mutation, sh...
$セラス ライフサイエンシズ グループ(SLS.US)$Sellas Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in Regal Phase 3 Study
Definitely still consider myself a newbie and what I have learnt so far is DCA works and to always take profit when you are up as the saying goes you can't go broke taking profit So many ups & downs and sometimes it is best to cut your losses! The sooner u cut your losses the more capital u have to reinvest into the winning ones
セラス ライフサイエンシズ グループに関するコメント
NEWS
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
SELLAS Life Sciences Group, Inc. announces positive Phase 2 preliminary data of SLS009 in relapsed/refractory acute myeloid leukemia (r/r AML), achieving a 100% response rate in patients with ASXL1 mutation at the optimal dose level. The company has filed IP protection related to the ASXL1 mutation, sh...
So many ups & downs and sometimes it is best to cut your losses! The sooner u cut your losses the more capital u have to reinvest into the winning ones
まだコメントはありません